SynthesisPLoS neglected tropical diseases2026
Disability as a neglected outcome of neglected tropical diseases: A systematic review.
Synthesis in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeglected tropical diseases (NTDs) affect more than one billion people worldwide, predominantly in low-resource settings. While substantial progress has been made in reducing transmission and mortality, the long-term disabilities resulting from NTDs remain insufficiently recognized and inadequately addressed within control programs.
objectiveTo identify, describe, and systematize the types of disabilities reported among individuals affected by NTDs, providing a comprehensive overview of the magnitude and diversity of long-term functional impairments associated with these conditions.
methodsThis systematic review was conducted in accordance with PRISMA 2020 guidelines. A comprehensive search was performed in PubMed, Cochrane Central, Embase, CINAHL, LILACS, and Web of Science databases, without restrictions on language or publication date. Studies reporting long-term disabilities or sequelae in individuals diagnosed with WHO-listed NTDs were included. Data on study characteristics, population demographics, and disability types were extracted and synthesized descriptively. Methodological quality was assessed using design-specific tools (MINORS, CARE checklist, and Jadad scale).
resultsThe initial search identified 958 records across databases. After removal of duplicates (n = 478), 480 records were screened, of which 310 were assessed for full-text eligibility. Following the application of inclusion and exclusion criteria, 130 studies were included in the final analysis, encompassing 551,574 individuals from 25 countries. Overall, 29% (n = 158,104) of evaluated individuals presented with at least one form of disability. Physical and motor impairments were the most prevalent (24.6%, n = 135,683), predominantly associated with leprosy-related neuropathic and musculoskeletal sequelae. Visual impairment was the second most frequent disability (1.81%, n = 10,007), largely attributable to trachoma and onchocerciasis. Cardiovascular, neurological, psychological, and social impairments were also reported. Considerable heterogeneity and underreporting of disability outcomes were observed across studies.
conclusionsDisability represents a substantial and underappreciated outcome of NTDs, extending far beyond infection-related morbidity. The high burden of long-term physical, visual, and other functional impairments underscores the urgent need to integrate disability assessment, rehabilitation services, and disability-inclusive development into NTD control strategies. Addressing these gaps is essential to advance patient-centered care and achieve the broader goals of the WHO NTD Roadmap and Universal Health Coverage.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.